Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Capital Employed (2020 - 2025)

Legend Biotech filings provide 6 years of Return on Capital Employed readings, the most recent being 51.73% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 2665.0% to 51.73% in Q4 2025 year-over-year; TTM through Dec 2025 was 51.73%, a 2665.0% increase, with the full-year FY2025 number at 12.81%, up 808.0% from a year prior.
  • Return on Capital Employed hit 51.73% in Q4 2025 for Legend Biotech, up from 39.64% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 3115.44% in Q2 2024 to a low of 2307.76% in Q3 2021.
  • Median Return on Capital Employed over the past 5 years was 39.64% (2025), compared with a mean of 486.2%.
  • Biggest five-year swings in Return on Capital Employed: surged 307552bps in 2024 and later plummeted -308115bps in 2025.
  • Legend Biotech's Return on Capital Employed stood at 1781.34% in 2021, then skyrocketed by 103bps to 45.59% in 2022, then surged by 6138bps to 2843.96% in 2023, then tumbled by -99bps to 25.08% in 2024, then skyrocketed by 106bps to 51.73% in 2025.
  • The last three reported values for Return on Capital Employed were 51.73% (Q4 2025), 39.64% (Q3 2025), and 34.29% (Q2 2025) per Business Quant data.